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Abstract
Background: Sea urchins can be found throughout the Brazilian coast and are reported to be one of the major
causes of marine accidents on the shoreline. Although not lethal, these accidents are reported to be extremely
painful. In order to understand the toxinology of the Brazilian urchins, a peptidomic approach was performed
aiming to characterize the naturally occurring peptides in both the coelomic fluid and the spine.
Methods: Animals were collected without gender distinction and samples of the coelomic fluid and spines
extracted were analyzed by RP-HPLC and mass spectrometry for peptide de novo sequencing.
Results: Several peptides were identified either in the coelomic fluid or the spine extract (except for E. lucunter).
The peptide sequences were aligned with public deposited sequences and possible functions were inferred.
Moreover, some peptides can be cryptides, since their sequences were identified within functional proteins, for
example thymosin from Strongylocentrotus purpuratus.
Conclusions: Although preliminary, the peptidomic approach presented here reports, for the first time, the abundance
of novel biological molecules derived from these animals. The discovery of such molecules may be of potential
biotechnological application, as described for other organisms; nevertheless, further studies are required.
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Background
Peptides are molecules that fill gaps in current therapeutic
approaches, between small organic molecules (<500 Da)
and the so-called ‘true’ biologicals (>5000 Da). It is
thought that peptides represent a class of potential inter-
esting biotechnological molecules to be developed, regard-
ing their specificity and high potency versus the (relative)
small size and lower manufacture costs. Issues regarding
their biodistribution and enzymatic degradation had dis-
couraged their development as drugs, but these problems
can now be bypassed by using new formulations and/or
injectable solutions [1, 2].
Peptides are being assayed for several uses, and clinical
trials are being conducted for peptide drugs [1]. The
marine biodiversity has already provided molecules with
therapeutic potential; therefore, they comprise a good
source of molecules that has been poorly explored. Marine
animals synthesize/secrete/process molecules for several
purposes, including chemical defense against predators,
microorganisms and even digestion, constituting a broad
arsenal waiting to be explored. Among the already de-
scribed molecules isolated from marine organisms, terpe-
noids, alkaloids, steroids and peptides can be included [3].
The mass spectrometry-based investigation of pep-
tides, or peptidome, is a fast and efficient technique to
identify peptides present in a given sample. This ap-
proach was employed in this work to identify peptides
in three Brazilian sea urchin species. These animals
are commonly found in Brazil, along the whole coast-
line. Echinometra lucunter, Lytechinus variegatus and
Arbacia lixula are the most abundant species of sea
urchins in Brazil.
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E. lucunter is a widespread species, commonly found
in shallow waters (in tide pools and reef slopes) [4]. A.
lixula and L. variegatus are also found in reef slopes, but
mainly in the sandy bottom [5]. The composition of
their venoms, regarding the molecules actually present
in those sea urchin species, has never been not fully de-
scribed; however, some biological activities have already
been reported for E. lucunter sea urchin, clearly signal-
ing for the presence of bioactive molecules [6–8].
The aim of the present work was to identify peptides
in coelomic fluid and spine extract of three Brazilian sea
urchins, and correlate them to already described peptides
and respective biological activities.
Methods
Sea urchin collection
Sea urchins (Echinometra lucunter, Lytechinus variegatus
and Arbacia lixula) were collected in São Sebastião, SP,
Brazil, under license number 13852–1 from the Brazilian
Institute of Environment and Renewable Natural Re-
sources (IBAMA) and in partnership with the Center for
Marine Biology (CEBIMar/USP).
Animals were collected without distinction of gender,
age or size. The coelomic fluid (circa 30 mL) was ex-
tracted from the sea urchin by puncturing the peristomial
membrane. Spines were removed and immersed in a buff-
ered solution (ammonium acetate 100 mM, pH 7.3) for
molecule extraction for 24 h, at 4 °C.
Solid phase extraction fractioning
The coelomic fluid and spine extracts were submitted to
solid phase extraction (SPE), in C18 cartridges (Phenom-
enex) and contents were eluted with 0, 25, 50 and 100 %
acetonitrile in ultrapure water, containing 0.1 % trifluor-
oacetic acid. Fractions were lyophilized and submitted to
mass spectrometry analysis.
Mass spectrometry analysis
Analyses were performed by RP-HPLC coupled to an ESI-
IT-ToF mass spectrometer (Shimadzu Co., Japan). Frac-
tions from SPE were loaded into a C18 column (2.1 ×
50 mm, 100 A, Phenomenex) and the elution was carried
out in gradient mode, with two solvents: (A) ultrapure
water containing 0.1 % acetic acid, (B) acetonitrile 90 % in
ultrapure water containing 0.1 % acetic acid. The gradient
was performed in 0 to 100 % B for 30 min.
After UV detection by HPLC, eluted molecules were
automatically analyzed by mass spectrometry, under
positive ionization mode. The interface voltage was kept
at 4.5 kV, the detector voltage at 1.70 kV and the capil-
lary temperature at 200 °C. The mass range used was
100–2000 m/z. Data dependent acquisition (DDA) MS/
MS analysis was performed.
MS and MS/MS data were processed by PEAKS®
7.0 software (Bioinformatics Solution Inc.) and manu-
ally checked for accuracy and correctness. De novo
sequences were searched against peptide databank
(PepBank) [9]. In addition, a database of peptides was
manually constructed with published data from other
sea urchins species [10–13]. These described peptides
were aligned with the de novo sequences by Clustal
Omega multiple sequence alignment, with output for-
mat without numbers, mBed-like clustering guide-tree
and iteration.
Results
Figures 1 and 2 are the representative total ion chro-
matogram (TIC) for SPE extractions of the biological
samples analyzed in this study. Figure 1 contains the
TIC chromatograms of the RP-HPLC analyses of the
25 % SPE of coelomic fluid from three sea urchins. A1
and A2 were selected as representative peaks to which
complementary analyses are presented in Fig. 3. Figure 2
contains the TIC of the 50 % SPE fractions of sea urchin
spine extracts. It is noteworthy to mention the differ-
ences between the species and the low abundance and
poor composition of E. lucunter spine extract, as previ-
ously reported [8].
Figure 3 contains two representative analyses of dis-
tinct peaks selected from Fig. 1 (A1 and A2) based solely
on their relative abundance, but bearing similar hydro-
phobicity, e.g. RP-HPLC retention times. Figure 3, panel
A, contains the MS1 and MS2 spectra of A2, the second
largest TIC peak in A. lixula chromatogram. It is clear
from the low m/z (415.24; z = 1) and fragmentation pat-
tern that this molecule is not a peptide. This was the
case for the vast majority of the larger peaks for all proc-
essed biological samples from all animals. Figure 3, panel
B, contains the MS1 and MS2 spectra of A1, one of the
several minor TIC peaks detected in A. lixula chromato-
gram. One can observe that, besides being a more com-
plex RP-HPLC fraction, some higher m/z values could
be detected. The 839.35 (z = 2) ion was selected and its
MS2 is presented in an inset. Simple visual inspection of
the daughter ions indicates the peptidic nature of the
precursor molecule. This spectrum was processed by
PEAKS® Studio 7.0 and manually checked for accuracy
and precision, as presented in Fig. 3, panel C. This whole
rationale was employed for all peaks, from all chromato-
grams of the three different animals, yielding the many
peptides presented in Tables 1 and 2.
Even though the direct proteomic approach (e.g.,
spectrum matching) yielded no results in the public data-
bases (NCBI), several de novo sequences of peptides could
be obtained for the three analyzed species, in both spines
(except for E. lucunter) and coelomic fluid as shown in
Tables 1 and 2, respectively, and in Additional file 1.
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Fig. 1 TIC chromatograms of the RP-HPLC analyses of coelomic fluid from 25 % SPE of three sea urchins. A1 and A2 were selected as representative
peaks to which complementary analyses are presented in Fig. 3
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Fig. 2 TIC chromatograms of the 50 % SPE fractions of sea urchin spine extracts
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Arbacia lixula seemed to contain more peptides than the
other two species, in spines and coelomic fluid, whereas
Lytechinus variegatus possess an equivalent number of
peptides in coelomic fluid and spines. For Echinometra
lucunter it was not possible to retrieve peptides from the
spines – only in coelomic fluid.
These sequenced peptides were then checked against a
peptide database (PepBank) and some similarities could
be identified, as listed in Table 3. Interesting biological
activities were found for the matched sequences, such as
antibiotic, antitumor, phospholipase A2 inhibitors or neu-
roprotective. A similarity was also found with a toxin from
scorpion venom, which confirms the presence of toxins in
sea urchins, as recently described by our group [6, 7].
Moreover, de novo sequenced peptides were aligned
with other described peptides from sea urchins, espe-
cially Strongylocentrotus purpuratus, the most studied
species. Some peptides have similar sequences, as shown













































Fig. 3 a MS1 and MS2 (inset) spectra of A2 [Fig. 1]. b MS1 and MS2 (inset) spectra of A1 [Fig. 1]. c PEAKS® Studio processed m/z 839.35 MS2 spectrum
with the deduced sequence above the annotated peaks
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in Additional file 2, with thymosin, halocyntin papillosin,
centrocin, AjANP1, AjANP2, AjPPLN2a and other
neuropeptides.
Discussion
Peptides from natural sources are gaining increasing at-
tention as drug leads. In this regard, marine animals
have an arsenal of molecules, only a few explored in the
drug development field.
Peptides from marine animals have already been de-
scribed, such as those from cone snails and sea anemones.
Conus venom is rich in peptides, called conotoxins, found
in several species. Conotoxins generally bind to ionic
channels as agonists or antagonists, causing a paralyzing
effect on prey [14, 15]. Despite the toxic effects of the
venom, one peptide was isolated, tested for analgesic ac-
tivity and showed good pharmacological effects and low
toxicity. It is currently under clinical trials for chronic pain
treatment [16].
Considering the potential of peptides as drug leads
and the fact that marine animals are a rich source of
such molecules, peptidomic studies were performed in
Brazilian sea urchin species in order to prospect new
peptides. To the best of our knowledge, this is the first
time these animals are studied from this perspective.
Although few peptides had been previously reported
from sea urchin samples, our group recently described a
peptide (echinometrin) from the coelomic fluid of Echi-
nometra lucunter sea urchin, which was selected based
on biological-driven assays. The eight-residue peptide
(LRKLMLQR) is active over mast cells, promoting hista-
mine release and, consequently, arising an inflammatory
reaction in mice [6]. However, in the present work – in
which high-throughput DDA de novo sequencing pepti-
domic approach was performed – echinometrin was not
identified, not only because it is present in low concen-
trations, but also because of its low hydrophobicity
index, e.g., low C18-RP-HCPL retention time. Moreover,
the analytical LC-MS/MS method employed in the
current study differed from the MS analysis regarding
the first 5 min of chromatographic separation, since no
Table 1 Peptides identified and de novo sequenced in coelomic
fluid of sea urchins



























Table 2 Peptides identified and de novo sequenced in the
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buffer or residual proteomic reagents (such as IAA,
DTT, urea) were injected into the mass spectrometer,
which causes the loss of extremely hydrophilic molecules.
Nevertheless, several other peptides (n = 22) present in E.
lucunter coelomic fluid could be identified. Some of them
are related to marine known peptides, for instance PPVF,
which is part of SpurS1, a neuropeptide from Strongylo-
centrotus purpuratus [10]. LGSR and LPPP are similar to
neuropeptides that act on prothoracic glands or could be
internal peptides of factor VIII, scorpion toxin Tc61, hu-
man neutrophil NADPH oxidase factor 2 or dipeptidyl
carboxypeptidase.
Some of the peptides described in the present study
could be aligned with others from sea urchins, which
suggests the presence of bioactive peptides in Brazilian sea
urchins. For example, antimicrobial peptides were aligned,
indicating the presence of peptides with this function,
which are present in many animals, especially marines,
due to the environment rich in microorganisms [17, 18].
EDGAPDVSEVGGTFDQ, PSVGVVTLPTELPQ and
QPMVVLCLVSTFDKSK were aligned with thymosin
from S. purpuratus (Additional file 2). Thymosin acts on
actin filament organization by sequestering actin mono-
mers. Based on our previous studies on peptide toxins, it
is our understanding that thymosin may be a source of
cryptides that are bioactive peptides generated proteo-
lytically from a non-precursor protein, by non-classical
processing enzymes, and that display biological activities
related or unrelated to the original protein [19]. The
fragments of thymosin described herein were sequenced
from secretions, not from cell lysates (e.g., intracellular).
Moreover, these three peptides are derived from one
single molecule, which indicates a possible ‘natural’ cleav-
age (not processing or artifact) generating peptides whose
effects could be different from the original one (actin
organization). For example, Schillaci et al. [11] have already
reported that thymosin fragments, from S. purpuratus,
possess antimicrobial activity. Nevertheless, complimentary
experiments are necessary to evaluate this hypothesis.
Spines have also been reported as a potential source of
bioactive molecules, since biological effects had been ob-
served in spine extracts. Briefly, an inflammatory reac-
tion in mice was described for the spine extract of
Echinometra lucunter, confirming the presence of toxins
in these structures [8]. Moreover, our group could iden-
tify a cathepsin B/X activity in spines, indicating the
presence of enzymes for either chemical defense of the
animal or tissue remodeling after injury, a frequent
phenomenon observed in our collections [7].
In the same study from 2011, we have observed that
spines are rich in small molecules, but no peptides are
present [8]. These results were corroborated by the pepti-
domic approach, presented in the current work, in which
we could not identify peptides in spines of Echinometra
lucunter.
Lytechinus variegatus, on the other hand, presented
peptides in both the spines and coelomic fluid. Although
a few molecules have been described, biological effects
have been related to this species, indicating the presence
of active molecules. In 1963, Mendes et al. [20] reported
an acetylcholine-like activity in the pedicellaria of L. var-
iegatus, and that this molecule was deactivated when
heated or submitted to NaOH, a situation typical for
peptides or proteins. Nevertheless, this molecule (or
molecules) has never been biochemically characterized.
In fact, several biological activities can be related to L.
variegatus peptides obtained by de novo sequencing. FLSY,
for example, is a phospholipase A2 inhibitor and LVAL has
antiviral activity. Moreover, AAHE was aligned with cen-
trocin1a, an antimicrobial peptide from Strongylocentrotus
droebachiensis; whereas VNDGTAALVVDNGSGFKV was
aligned with papilosin, and GHNGY and MLGGAH were
aligned with halocyntin [12, 13]. Papilosin and halocyntin
are antimicrobial peptides obtained from hemocytes of the
red sea squirt Halocynthia papillosa. These cells, respon-
sible for phagocytosis and involved in the immune system,
are also find in abundance in coelomic fluid of sea urchins
[13]. Peptides similar to papilosin and halocyntin were
identified in coelomic fluid of L. variegatus, which indicates
the presence of antimicrobial molecules that are essential
for maintenance of “sterile” conditions.
Arbacia lixula was the sea urchin with the largest
number of identified peptides, both in spines and in
coelomic fluid. From the latter, the sequenced peptides
related to already described ones (not only marine)
matched: an antimicrobial peptide, a peptide liberated by
Table 3 Search of de novo sequenced peptides of sea urchins
in PepBank
Peptide Origin Function (possible)
DVKL A. lixula – coelomic fluid Antibiotic and anticancer
FLSY L. variegatus – coelomic
fluid
Phospholipase A2 inhibitor
LDLR A. lixula – coelomic fluid Peptide in thrombin-liberated
human/eglin (inhibitory activity
towards human leukocyte elastase,
cathepsin G, porcine pancreatic
elastase and alpha-chymotrypsin)
LGSR E. lucunter – coelomic fluid Brain peptide for activation of
prothoracic gland, factor VIII
activity, toxin Tc61 (scorpion),
human neutrophil NADPH
oxidase factor 2
LLLL A. lixula – coelomic fluid Antimicrobial, neuroprotective
LPPP E. lucunter – coelomic fluid Dipeptidyl carboxypeptidase
substrate
LVAL L. variegatus – spines Antiviral
PESL A. lixula – coelomic fluid Membrane-bound aminopeptidase
P, protein tyrosine kinases
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thrombin, inhibitory peptides towards human leukocyte
elastase, cathepsin G, porcine pancreatic elastase, alpha-
chymotrypsin, neuroprotective peptides, membrane-bound
aminopeptidase P and protein tyrosine kinases fragments.
Since L. variegatus centrocin 1a and 2 also matched se-
quenced peptides from coelomic fluid of A. lixula, it is
our opinion that antimicrobial peptides would be present
in this sea urchin species. Corroborating this idea, halo-
cyntin was also found in A. lixula, and interestingly, in
both coelomic fluid and spines. Moreover, there was also
matching with papillosin, another antimicrobial peptide.
Conclusions
This work reported, for the first time, the presence of pep-
tides on the coelomic fluid and spines of three different
species of Brazilian sea urchins. By sequence comparison
and alignment, some biological activities, especially anti-
microbial, could be inferred.
Currently, several peptides are being used as drug
leads and other biotechnological applications, so the
discovery of new structures could be a starting point for
future drug development. Here, we present the Brazilian
sea urchins as potential sources of novel peptides, and
this initial biochemical characterization may lead to a
better understanding of the chemical ecology of the
animal, as well as unveil potential biotechnological appli-
cation for this marine organism.
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